Search Tag: immunotherapy
2019 01 May
A randomised controlled multicentre trial assessed for the first time the safety and pharmacokinetics of an antiprogrammed cell death-ligand 1 (anti–PD-L1) immune checkpoint inhibitor (BMS-936559; Bristol-Myers Squibb, Princeton, NJ) and its effect on immune biomarkers in participants with sepsis-associated immunosuppression. Results show that...Read more
2016 04 Nov
CytoSorbents Corporation , a critical care immunotherapy leader commercializing its flagship CytoSorb® extracorporeal cytokine adsorber to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the addition of Belgium and Luxembourg to its direct sales territories. CytoSorb is now distributed in 42...Read more
2014 13 May
A study recently published in the Journal of Immunology Research reports that patients with highest levels of the most powerful version of the immune molecule HLA-G seem to have the lowest risk of rejecting their transplanted kidney. Dr. Anatolij Horuzsko, immunologist at the Medical College of Georgia at Georgia Regents University and the study's...Read more